Abstract:The self-assembly of proteins and peptides into ordered structures called amyloid fibrils is a hallmark of numerous diseases, impacting the brain, heart, and other organs. The structure of amyloid aggregates is central to their function and thus has been extensively studied. However, the structural heterogeneities between aggregates as they evolve throughout the aggregation pathway are still not well understood. Conventional biophysical spectroscopic methods are bulk techniques and only report on the average structural parameters. Understanding the structure of individual aggregate species in a heterogeneous ensemble necessitates spatial resolution on the length scale of the aggregates. Recent technological advances have led to augmentation of infrared (IR) spectroscopy with imaging modalities, wherein the photothermal response of the sample upon vibrational excitation is leveraged to provide spatial resolution beyond the diffraction limit. These combined approaches are ideally suited to map out the structural heterogeneity of amyloid ensembles. AFM-IR, which integrates IR spectroscopy with atomic force microscopy enables identification of the structural facets the oligomers and fibrils at individual aggregate level with nanoscale resolution. These capabilities can be extended to chemical mapping in diseased tissue specimens with submicron resolution using optical photothermal microscopy, which combines IR spectroscopy with optical imaging. This book chapter provides the basic premise of these novel techniques and provides the typical methodology for using these approaches for amyloid structure determination. Detailed procedures pertaining to sample preparation and data acquisition and analysis are discussed and the aggregation of the amyloid β peptide is provided as a case study to provide the reader the experimental parameters necessary to use these techniques to complement their research efforts.

Experimental techniques for detecting and evaluating the amyloid fibrils

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Experimental procedures to investigate fibrillation of proteins

Interrogating Amyloid Aggregation with Aggregation-Induced Emission Fluorescence Probes.

Techniques for monitoring protein misfolding and aggregation in vitro and in living cells

Pathways of amyloid fibril formation and protein aggregation

Factors influencing amyloid fibril formation

Kinetic Analysis of Amyloid Formation

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Structural characterization of amyloid aggregates with spatially resolved infrared spectroscopy

Fundamentals and exploration of aggregation-induced emission molecules for amyloid protein aggregation

Morphological features and types of aggregated structures

Therapeutic Interventions for the Suppression of Alzheimer'S Disease: Quest for A Remedy

Screening Carbon Nano Materials for Preventing Amyloid Protein Aggregation by Adopting a Facile Method

Experimental Characterization of Disordered and Ordered Aggregates Populated During the Process of Amyloid Fibril Formation.

Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution

Physicochemical Strategies for Inhibition of Amyloid Fibril Formation: an Overview of Recent Advances

Investigation of the Aggregation Process of Amyloid-Β-(16-22) Peptides and the Dissolution of Intermediate Aggregates.